Ligands participating in these interactions are known immunosuppressive molecules (e.g., Tgfb1, Il1b), pro-angiogenic factors (e.g., Vegfa), or other genes associated with tumor progression (e.g., Fn1, Apoe, Apoc2). The gene discussed is IL1B; the disease is neoplasm.